These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11950549)

  • 61. Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Nielsen SM; Toftdahl NG; Nordentoft M; Hjorthøj C
    Psychol Med; 2017 Jul; 47(9):1668-1677. PubMed ID: 28166863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relationships between symptoms of schizophrenia and substance abuse.
    Brunette MF; Mueser KT; Xie H; Drake RE
    J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment.
    Arndt S; Tyrrell G; Flaum M; Andreasen NC
    Psychol Med; 1992 May; 22(2):379-88. PubMed ID: 1615105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London.
    Duke PJ; Pantelis C; McPhillips MA; Barnes TR
    Br J Psychiatry; 2001 Dec; 179():509-13. PubMed ID: 11731353
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relapse in schizophrenia: is there a relationship to substance abuse?
    Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
    Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The consequences of Conduct Disorder for males who develop schizophrenia: associations with criminality, aggressive behavior, substance use, and psychiatric services.
    Hodgins S; Tiihonen J; Ross D
    Schizophr Res; 2005 Oct; 78(2-3):323-35. PubMed ID: 15996855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders.
    Mueser KT; Rosenberg SD; Drake RE; Miles KM; Wolford G; Vidaver R; Carrieri K
    J Stud Alcohol; 1999 Mar; 60(2):278-84. PubMed ID: 10091967
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The epidemiology of onset and course of schizophrenia.
    an der Heiden W; Häfner H
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(6):292-303. PubMed ID: 11153964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia.
    Mueser KT; Drake RE; Ackerson TH; Alterman AI; Miles KM; Noordsy DL
    J Abnorm Psychol; 1997 Aug; 106(3):473-7. PubMed ID: 9241949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: Findings from the Australian National Survey on Mental Health and Wellbeing.
    Degenhardt L; Glantz M; Bharat C; Peacock A; Lago L; Sampson N; Kessler RC
    Drug Alcohol Rev; 2018 May; 37(4):546-556. PubMed ID: 29505682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia.
    Häfner H; Löffler W; Maurer K; Hambrecht M; an der Heiden W
    Acta Psychiatr Scand; 1999 Aug; 100(2):105-18. PubMed ID: 10480196
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Substance use disorder and the early course of illness in schizophrenia and affective psychosis.
    Kovasznay B; Fleischer J; Tanenberg-Karant M; Jandorf L; Miller AD; Bromet E
    Schizophr Bull; 1997; 23(2):195-201. PubMed ID: 9165630
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Psychiatric comorbidity in hospitalized adolescent substance abusers.
    Hovens JG; Cantwell DP; Kiriakos R
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):476-83. PubMed ID: 8005900
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The psychosocial outcome of adolescent-onset schizophrenia: a 12-year followup.
    Lay B; Blanz B; Hartmann M; Schmidt MH
    Schizophr Bull; 2000; 26(4):801-16. PubMed ID: 11087013
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Onset and early course as determinants of the further course of schizophrenia.
    Häfner H
    Acta Psychiatr Scand Suppl; 2000; (407):44-8. PubMed ID: 11261639
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia.
    Smith MJ; Barch DM; Wolf TJ; Mamah D; Csernansky JG
    Schizophr Res; 2008 Dec; 106(2-3):294-9. PubMed ID: 18774264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.